NexPoint Life Sciences II DST of DALLAS, TX, a company, filed a Form D amendment with the SEC on 2025-11-20. The offering totals $40.5M, of which $40.5M was reported sold. Industry: Other Real Estate.
| Name | Role | Location |
|---|---|---|
| Matthew Goetz | Executive Officer | Dallas, TX |
| Matt McGraner | Executive Officer | Dallas, TX |
| N/A NexPoint Real Estate Advisors IV, L.P. | Executive Officer | Dallas, TX |
| N/A NREA Life Sciences II, LLC | Executive Officer | Dallas, TX |
| N/A NREA LS II Investment Co, LLC | Executive Officer | Dallas, TX |
Showing 15 of 18 filings.
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-11-07 | D/A | $40.5M | $39.6M |
| 2025-09-09 | D/A | $40.5M | $37.0M |
| 2025-04-21 | D/A | $40.5M | $31.1M |
| 2024-12-17 | D/A | $40.5M | $29.0M |
| 2024-10-30 | D/A | $40.5M | $27.9M |
| 2024-05-29 | D/A | $40.5M | $19.4M |
| 2024-04-22 | D/A | $40.5M | $19.4M |
| 2024-04-09 | D/A | $40.5M | $18.8M |
| 2023-12-13 | D/A | $40.5M | $11.3M |
| 2023-11-30 | D/A | $40.5M | $10.2M |
| 2023-11-15 | D/A | $40.5M | $9.7M |
| 2023-10-18 | D/A | $40.5M | $7.7M |
| 2023-09-26 | D/A | $40.5M | $6.3M |
| 2023-09-14 | D/A | $40.5M | $2.8M |
| 2023-08-18 | D/A | $40.5M | $1.8M |